Cardiac arrest

I9_CARDARR

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — I46 Hospital discharge: ICD-9 — 4275A\|4112 Hospital discharge: ICD-8 — 4272 Cause of death: ICD-10 — I46 Cause of death: ICD-9 — 4275A\|4112 Cause of death: ICD-8 — 4272 2 out of 7 registries used, show all original rules.	3097
4. Check minimum number of events None	3097
5. Include endpoints None	3097
6. Filter based on genotype QC (FinnGen only)	3097

Control definitions (FinnGen only)

Control exclude: FG_CVD

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: I30-I52
Name in latin: Asystolia

NAME	I9_CARDARR
CONTROL_EXCLUDE	FG_CVD
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	I46
HD_ICD_9	4275A\|4112
HD_ICD_8	4272
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	I46
COD_ICD_9	4275A\|4112
COD_ICD_8	4272
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Cardiac arrest based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	36836	12963	23118
Only index persons	22152	7645	14507
Unadjusted period prevalence (%)
Whole population	0.55	0.37	0.65
Only index persons	0.46	0.28	0.55
Median age at first event (years)
Whole population	68.10	71.19	66.35
Only index persons	68.17	71.52	66.40

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3097	848	2249
Unadjusted period prevalence (%)	0.80	0.29	0.99
Median age at first event (years)	67.68	64.78	68.78

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2448: Matched controls
22181

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

I50.9

ICD-10 Finland

Heart failure, unspecified

300.6

323.0

726

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

416.2

323.0

534

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

2016.8

323.0

362

C01DA14

ATC

isosorbide mononitrate; oral

33.7

323.0

616

219

I49.0

ICD-10 Finland

Ventricular fibrillation and flutter

439.7

323.0

374

I48

ICD-10 Finland

Atrial fibrillation and flutter

135.3

323.0

914

B01AC04

ATC

clopidogrel; oral

35.9

323.0

649

220

I25.1

ICD-10 Finland

Atherosclerotic heart disease

287.6

323.0

1210

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

154.1

323.0

469

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

211.2

323.0

409

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

18.0

323.0

770

549

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

28.5

323.0

866

417

WX872

NOMESCO Finland

Intensive care

47.8

323.0

454

105

AN1

Coronary angiography

109.0

323.0

641

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

368.0

323.0

404

C09AA05

ATC

ramipril; oral

10.0

323.0

994

1416

I50.0

ICD-10 Finland

Congestive heart failure

925.0

323.0

424

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

13.1

323.0

811

808

205

Kela drug reimbursment

Chronic hypertension

+∞

323.0

804

C07AB07

ATC

bisoprolol; oral

16.3

323.0

1660

2530

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

108.4

323.0

1203

196

I50.1

ICD-10 Finland

Left ventricular failure

3845.8

323.0

373

207

Kela drug reimbursment

Chronic arrhythmias

284.1

323.0

577

201

Kela drug reimbursment

Chronic cardiac insufficiency

144.4

323.0

401

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

24.9

323.0

1118

722

C03CA01

ATC

furosemide; systemic

15.8

323.0

1209

1288

B01AA03

ATC

warfarin; systemic

50.7

323.0

831

222

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

+∞

323.0

350

C03DA01

ATC

spironolactone; oral

22.0

323.0

526

272

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

116.3

323.0

997

130

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

353.5

323.0

637

I46.9

ICD-10 Finland

Cardiac arrest, unspecified

+∞

323.0

427

I25.2

ICD-10 Finland

Old myocardial infarction

2978.7

323.0

542

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

+∞

323.0

1849

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

+∞

312.3

304

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

9.8

311.6

709

883

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

91.2

310.8

354

I10

ICD-10 Finland

Essential (primary) hypertension

5.1

291.8

1363

4398

I47.2

ICD-10 Finland

Ventricular tachycardia

1429.7

281.5

279

C01AA05

ATC

digoxin; systemic

45.4

280.5

357

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

+∞

275.5

269

AA1AD

NOMESCO Finland

CT of head and brain

6.3

274.4

888

1836

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

1377.3

273.1

271

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

83.5

272.3

314

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

+∞

256.7

251

TFP20

NOMESCO Finland

Cardiodefibrillation

649.8

255.9

258

I42.0

ICD-10 Finland

Dilated cardiomyopathy

+∞

252.5

247

C07AB02

ATC

metoprolol; systemic

8.6

252.4

617

837

WX730

NOMESCO Finland

Conventional respirator

69.0

249.9

296

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

+∞

246.3

241

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

141.3

242.8

265

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

+∞

242.1

237

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

+∞

233.8

229

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

87.8

233.6

268

G93.1

ICD-10 Finland

Anoxic brain damage, not elsewhere classified

392.4

230.9

237

Angiography of the heart and coronary arteries

63.9

226.1

271

XF400

NOMESCO Finland

ECG with 12 standard connections

6.8

218.7

629

1066

GD1AA

NOMESCO Finland

Thorax X-ray examination

4.0

213.8

1241

4495

I20.09

ICD-10 Finland

Unstable angina

1953.3

209.7

208

FPG30

NOMESCO Finland

Implantation of cardioverter-defibrillator with ventricular electrode

+∞

206.8

203

C10AA05

ATC

atorvastatin; oral

4.1

203.1

1102

3710

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

6.7

200.8

579

973

C01BD01

ATC

amiodarone; systemic

500.8

200.1

204

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

40.2

198.4

259

WX930

NOMESCO Finland

Thepapeutic hypothermia

1815.9

196.2

195

B01AC24

ATC

ticagrelor; oral

1763.5

191.1

190

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

75.8

188.8

221

K78

ICPC

Atrial fibrillation/flutter

53.8

188.1

232

WX892

NOMESCO Finland

Monitored bed care

13.5

186.3

345

265

B01AF02

ATC

apixaban; oral

41.4

185.1

240

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

1872.2

182.8

182

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

208.0

179.7

191

TPH07

NOMESCO Finland

Cathetrisation of artery

7.9

178.3

448

607

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

15.7

177.2

307

200

I20.99

ICD-10 Finland

Angina pectoris, unspecified

82.5

173.6

201

FPG32

NOMESCO Finland

Implantation of cardioverter-defibrillator with atrial and ventricular electrodes

+∞

171.7

169

AN4

Balloon angioplasty and drug eluding stent

+∞

164.4

162

C08CA01

ATC

amlodipine; oral

4.0

163.6

825

2493

C10AA01

ATC

simvastatin; oral

3.4

163.4

1196

4892

C09AA02

ATC

enalapril; systemic

5.5

162.0

551

1113

XF404

NOMESCO Finland

Ambulatory ECG

12.3

162.0

313

261

A12BA01

ATC

potassium chloride; oral

159.9

152.2

165

J18.9

ICD-10 Finland

Pneumonia, unspecified

3.8

149.5

809

2562

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

216.6

147.9

157

I21.01

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

+∞

144.9

143

FN1BT

NOMESCO Finland

Extensive endovascular dilatation of coronary (PTCA) arteries

+∞

143.9

142

I46.1

ICD-10 Finland

Sudden cardiac death, so described

+∞

143.9

142

AN3

Balloon angioplasty and metallic stent

+∞

141.9

140

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1379.3

141.8

142

I21.99

ICD-10 Finland

Myocardial infarction (acute) UNS unspecified coronary artery status

+∞

138.8

137

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

23.4

138.3

207

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

4.2

138.2

616

1624

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

1309.1

135.7

136

103

Kela drug reimbursment

Diabetes, insulin-treated

3.7

133.5

719

2233

I35.0

ICD-10 Finland

Aortic (valve) stenosis

51.2

131.8

164

I44.2

ICD-10 Finland

Atrioventricular block, complete

+∞

129.6

128

I20.01

ICD-10 Finland

Unstable angina

+∞

129.6

128

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

149.1

128.4

140

AN2

Balloon angioplasty, including several vessels

+∞

125.5

124

GD1LA

NOMESCO Finland

121.1

125.1

139

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

56.3

124.2

152

C10AX09

ATC

ezetimibe; oral

7.2

123.9

329

470

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

82.0

118.2

137

I25

ICD-10 Finland

Chronic ischaemic heart disease

42.7

117.4

151

C08DB01

ATC

diltiazem; oral

25.5

117.4

171

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

14.5

117.0

208

141

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

8.4

116.9

277

331

R06.0

ICD-10 Finland

Dyspnoea

3.8

116.9

600

1762

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

9.2

116.4

261

284

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

16.9

114.5

191

110

M04AA01

ATC

allopurinol; systemic

4.9

114.3

418

887

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

62.4

113.8

137

TK800

NOMESCO Finland

Hemodialysis

47.9

111.3

140

I21.40

ICD-10 Finland

Acute subendocardial infarction no detected stenosis of the coronary artery

1060.2

111.2

112

42728

ICD-8 Finland

Symptomatic heart disease, Dissociatio cordis alia

+∞

111.2

110

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

4.1

110.1

492

1271

R4110

NOMESCO Finland

Physiotherapy

3.2

110.1

744

2683

B01AC06

ATC

acetylsalicylic acid; oral (platelet aggregation inhibitors excl. heparin)

68.8

109.6

130

XF402

NOMESCO Finland

ECG with work load test

6.7

108.4

300

451

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

105.5

108.3

122

TPH04

NOMESCO Finland

Cathetrisation of vein

3.6

107.0

572

1720

C08CA02

ATC

felodipine; oral

9.7

107.0

232

237

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

180.1

106.0

114

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

8.3

105.6

251

300

I20.00

ICD-10 Finland

Unstable angina

509.0

105.5

108

A10BA02

ATC

metformin; oral

3.2

105.4

698

2467

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

11.9

103.6

201

165

C02EA02

ATC

72.0

102.6

121

I21.09

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

+∞

102.0

101

AA1

Conventional CABG

+∞

102.0

101

I49.5

ICD-10 Finland

Sick sinus syndrome

32.2

100.9

138

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

6.4

99.6

286

450

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

128.9

98.7

109

PH1AC

NOMESCO Finland

Flebography of over extremity with X-ray

245.8

98.5

104

I21.9

ICD-10 Finland

Acute myocardial infarction, unspecified

474.4

98.4

101

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

7.5

97.1

247

327

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

+∞

94.9

I20.90

ICD-10 Finland

Angina pectoris, unspecified

233.2

93.5

A10AE04

ATC

insulin glargine; parenteral

6.0

92.7

280

469

XA800

NOMESCO Finland

Neuropsychological investigation

10.4

91.0

189

177

I21.00

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

+∞

90.8

Coronary artery bypass surgery

+∞

88.8

N17.9

ICD-10 Finland

Acute renal failure, unspecified

14.1

87.8

157

107

Single vessel balloon catheter extension

+∞

86.8

4100X

ICD-9 Finland

Acute myocardial infarction, Of anterolateral wall[INFARCTUS MYOCARDII ACUTUS DEFINITUS,MÄÄRITTELEMÄT]

+∞

86.8

C09BA02

ATC

enalapril and diuretics; systemic

8.4

86.7

203

235

C07AA07

ATC

sotalol; systemic

16.9

86.0

143

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

44.3

84.7

108

I21.90

ICD-10 Finland

Myocardial infarction (acute) UNS no detected stenosis of the coronary artery

+∞

84.7

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

+∞

84.7

C09DX04

ATC

valsartan and sacubitril; oral

+∞

84.7

C07AG02

ATC

carvedilol; oral

12.5

82.6

156

120

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

140.8

82.1

FNC20

NOMESCO Finland

Aorto-coronary venous bypass with two distal anastomoses

+∞

81.7

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

4.5

81.1

318

710

I21.11

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

+∞

80.7

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

95.0

80.0

K84

ICPC

Heart disease other

43.2

78.9

101

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

259.9

78.8

AS7

Arrhythmia pacemaker insertion VVI (R) S

+∞

78.6

R07.4

ICD-10 Finland

Chest pain, unspecified

2.9

78.6

568

2072

C02DE04

ATC

196.6

78.5

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

253.2

76.8

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

+∞

76.6

WX900

NOMESCO Finland

Resuscitation

82.6

76.1

I50

ICD-10 Finland

Heart failure

54.6

75.8

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

11.5

75.6

148

123

I47.1

ICD-10 Finland

Supraventricular tachycardia

47.0

75.4

C03AA03

ATC

hydrochlorothiazide; oral

6.8

75.2

202

287

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

112.3

75.1

TFP34

NOMESCO Finland

Electrophysiological investigation

81.6

75.1

FPG96

NOMESCO Finland

Other implantation of permanent cardioverter-defibrillator

+∞

74.6

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

357.1

74.2

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

6.1

73.6

215

342

FNC30

NOMESCO Finland

Aorto-coronary venous bypass with three distal anastomoses

+∞

73.6

381

Kela drug reimbursment

Combination product containing sacubitril and valsartan

+∞

73.6

A10BB12

ATC

glimepiride; oral

6.2

72.8

212

336

4019X

ICD-9 Finland

Essential hypertension, Unspecified

+∞

72.6

TKC20

NOMESCO Finland

Catheterisation of bladder

4.7

72.4

268

562

FPE30

NOMESCO Finland

Replacement of transvenous cardiac pacemaker pulse generator

108.2

72.2

C07AB03

ATC

atenolol; systemic

9.6

71.7

154

153

C02AC05

ATC

moxonidine; oral

18.9

71.6

114

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.6

71.0

356

988

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

669.4

70.7

ZX120

NOMESCO Finland

Intravenous

4.1

70.5

300

721

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

65.4

70.5

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

229.9

69.8

I21.19

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

+∞

69.5

FM1DG

NOMESCO Finland

Very extensive MRI examination of heart with high intesity magnet

64.6

69.5

AP1

Catheterization of the left side of the heart

92.3

69.2

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

5.2

69.2

231

432

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.9

67.6

310

796

K76

ICPC

Ischaemic heart dis without angina

46.8

67.5

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

7.9

65.5

158

191

4273A

ICD-9 Finland

Cardiac dysrhythmias, Atrial fibrillation and flutter

+∞

65.5

280

Kela drug reimbursment

Clopidogrel

+∞

65.5

I71.4

ICD-10 Finland

Abdominal aortic aneurysm, without mention of rupture

87.5

65.3

N18.8

ICD-10 Finland

Other chronic renal failure

22.5

65.3

I48.1

ICD-10 Finland

Persistent atrial fibrillation

313.7

65.2

XFE00

NOMESCO Finland

Epicardial ultrasonography

27.0

64.6

Z49.1

ICD-10 Finland

Extracorporeal dialysis

71.0

64.5

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

308.9

64.2

45499

ICD-8 Finland

Varicose veins of lower extremities, Other and unspecified, without ulcer

+∞

63.4

FNC10

NOMESCO Finland

Aorto-coronary venous bypass with single distal anastomosis

+∞

63.4

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

13.3

63.0

115

I48.2

ICD-10 Finland

Chronic atrial fibrillation

+∞

62.4

TFP30

NOMESCO Finland

Cathetric examination for cardiac arrythmia

+∞

62.4

FPG40

NOMESCO Finland

Replacement of pulse generator in transvenous cardioverter-defibrillator

+∞

62.4

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

3.5

62.2

329

947

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

15.4

61.8

106

A46

ICD-10 Finland

Erysipelas

3.3

61.0

348

1061

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.6

60.8

517

2044

4120X

ICD-9 Finland

Old myocardial infarction[STATUS POST INFARCTUM CORDIS,MÄÄRITTELEMÄT]

+∞

60.4

A10AE05

ATC

insulin detemir; parenteral

6.6

59.0

161

233

K77

ICPC

Heart failure

43.7

58.9

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

545.1

57.7

I21.4

ICD-10 Finland

Acute subendocardial myocardial infarction

545.1

57.7

I44.1

ICD-10 Finland

Atrioventricular block, second degree

+∞

57.4

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

3.7

56.8

273

725

FPJ21

NOMESCO Finland

Revision of cardioverter-defibrillator with ventricular electrode

+∞

56.4

A11CC03

ATC

alfacalcidol; systemic

28.4

56.3

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

4.2

55.9

229

527

A02BC02

ATC

pantoprazole; systemic

2.0

55.8

1396

8907

I21.0

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

+∞

55.3

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

9.6

54.7

117

115

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

95.9

54.6

TFP00

NOMESCO Finland

Temporary use of transvenous or epicardial pacemaker

516.6

54.6

4130X

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),MÄÄRITTELEMÄT]

+∞

54.3

A98

ICPC

Health maint/preventive medicine

0.5

54.0

1687

18300

D64.9

ICD-10 Finland

Anaemia, unspecified

3.7

53.9

261

696

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

+∞

53.3

I25.8

ICD-10 Finland

Other forms of chronic ischaemic heart disease

+∞

53.3

XF640

NOMESCO Finland

18.5

53.3

R03BB04

ATC

tiotropium bromide; inhalant

3.3

53.0

295

878

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

92.7

52.7

4120B

ICD-9 Finland

Old myocardial infarction[STATUS POST INFARCTUM CORDIS,AHTAUTUNUT]

+∞

52.3

Catheterization and pressure measurement of the left side of the heart

107.4

51.8

A10BB01

ATC

glibenclamide; oral

7.0

51.6

135

184

B01AB05

ATC

enoxaparin; parenteral

2.2

51.5

626

2944

J96.0

ICD-10 Finland

Acute respiratory failure

22.4

51.4

WX722

NOMESCO Finland

PEEP

5.7

51.4

157

263

4130B

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),AHTAUTUNUT]

+∞

51.3

WX882

NOMESCO Finland

High dependency care

8.4

50.6

117

132

R55

ICD-10 Finland

Syncope and collapse

3.4

50.5

268

768

1CX08

NOMESCO Finland

245.5

50.2

I21.10

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

+∞

49.3

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

2.7

49.2

396

1499

C08CA13

ATC

lercanidipine; oral

3.9

49.1

222

557

XF409

NOMESCO Finland

Other special ECG

74.1

47.9

T90

ICPC

Diabetes non-insulin dependent

2.4

47.8

475

2015

M10.9

ICD-10 Finland

Gout, unspecified

4.8

47.6

171

344

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

157.0

47.0

N18.0

ICD-10 Finland

End-stage renal disease

83.2

46.9

C09AA01

ATC

captopril; oral

36.0

46.9

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

10.9

46.7

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

7.4

46.6

117

150

N19

ICD-10 Finland

Unspecified kidney failure

9.1

46.5

102

105

AS4

Physiological pacemaker insertion DDD (R)

226.0

46.3

C01BC04

ATC

flecainide; systemic

28.3

45.7

GBB00

NOMESCO Finland

Tracheostomy

11.8

45.0

5CM18

NOMESCO Finland

115.4

45.0

N05CF01

ATC

zopiclone; oral

2.0

44.9

732

3866

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

7.9

44.8

107

127

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

+∞

44.2

I34.1

ICD-10 Finland

Mitral (valve) prolapse

29.7

44.2

WX408

NOMESCO Finland

General anesthesy, balanced

2.1

43.3

620

3096

C09CA03

ATC

valsartan; oral

4.2

43.3

178

409

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

110.7

43.0

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

5.1

42.9

143

265

J01MA12

ATC

levofloxacin; systemic

2.3

42.8

462

2031

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.1

42.8

616

3083

FN1CC

NOMESCO Finland

Very extensive angiography of heart and/or coronary arteries

39.1

42.4

FMD10

NOMESCO Finland

Replacement of aortic valve using biological prosthesis

+∞

42.2

42792

ICD-8 Finland

Symptomatic heart disease, Fibrillatio auricularis

+∞

42.2

PD5BD

NOMESCO Finland

Extensive CT of aorta

26.5

42.2

A12AA04

ATC

calcium carbonate; oral

34.5

42.1

B01AC07

ATC

dipyridamole; systemic

7.5

42.0

104

131

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

3.3

41.8

227

659

E87.5

ICD-10 Finland

Hyperkalaemia

20.5

41.7

Z50.0

ICD-10 Finland

Cardiac rehabilitation

202.5

41.3

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

202.5

41.3

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

202.5

41.3

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

5.0

41.2

141

269

A10BH01

ATC

sitagliptin; oral

3.6

40.9

203

549

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

6.9

40.6

106

144

FN2CA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), treating more than one main trunk during a single procedure

384.4

40.6

NHQ40

NOMESCO Finland

Amputation of toe

21.7

40.5

TK810

NOMESCO Finland

Hemofiltration

63.1

40.3

A28

ICPC

Limited function/disability NOS

2.6

40.3

332

1265

41099

ICD-8 Finland

Acute myocardial infarction, Without mention of hypertensive disease

+∞

40.2

40199

ICD-8 Finland

Essential benign hypertension

+∞

40.2

FNC40

NOMESCO Finland

Aorto-coronary venous bypass with four distal anastomoses

+∞

40.2

FPJ22

NOMESCO Finland

Revision of cardioverter-defibrillator with atrial and ventricular electrodes

+∞

40.2

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

135.0

40.2

WX704

NOMESCO Finland

Intubation

3.6

40.0

192

506

K99

ICPC

Cardiovascular disease other

14.2

39.4

Electrophysiological Special Examination

+∞

39.2

I20.91

ICD-10 Finland

Angina pectoris, unspecified

+∞

39.2

FN2AB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), drug-eluting balloon

365.6

38.6

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

5.5

38.5

120

206

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

+∞

38.2

AS8

Physiological arrhythmia pacemaker insertionDDD (R) S

+∞

38.2

XPX08

NOMESCO Finland

Intraoperative flow measurement

+∞

38.2

FL1AC

NOMESCO Finland

Left cardioangiography

44.2

38.0

A10AA02

ATC

7.2

37.9

125

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

6.7

37.8

101

142

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

12.0

37.6

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

53.0

37.6

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

6.6

37.4

101

144

I21.97

ICD-10 Finland

Suspected acute myocardial infarction

79.2

37.2

PE1AT

NOMESCO Finland

Femoral artery PTA

+∞

37.2

C09CA01

ATC

losartan; oral

2.2

37.1

439

2002

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

3.4

36.4

188

525

C02LM02

ATC

+∞

36.2

B04AB02

ATC

12.2

35.3

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

+∞

35.2

4549X

ICD-9 Finland

Varicose veins of lower extremities, Without mention of ulcer or inflammation

+∞

35.2

127

Kela drug reimbursment

Transplant complication

18.8

35.0

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

5.6

34.9

107

180

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.5

34.7

300

1167

A10BH05

ATC

linagliptin; oral

5.6

34.4

105

176

S97

ICPC

Chronic ulcer skin

4.6

34.2

125

256

J01FF01

ATC

clindamycin; systemic

2.0

34.2

564

2942

FN2CC

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA) of left main trunk

+∞

34.2

5315

FHL

Bypass surgery using a mammary artery

+∞

34.2

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

7.9

34.1

TFP35

NOMESCO Finland

Electroanatomical mapping

43.9

34.1

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

15.5

33.8

A41.9

ICD-10 Finland

Sepsis, unspecified

5.4

33.7

106

184

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

53.8

33.6

C10AA07

ATC

rosuvastatin; oral

2.1

33.4

460

2229

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.8

33.4

231

789

R00.1

ICD-10 Finland

Bradycardia, unspecified

8.4

33.4

TFC10

NOMESCO Finland

Catheterisation of left atrium or ventricle

31.9

33.3

E66.00

ICD-10 Finland

Metabolic syndrome

5.6

33.3

101

168

R02

ICPC

Shortness of breath/dyspnoea

2.8

33.2

227

770

I21.21

ICD-10 Finland

Acute transmural myocardial infarction with another location stenosed coronary artery

+∞

33.1

5611

FHL

Vena saphena Magna and / or swarm of nodule and possible local emissions

+∞

33.1

C10AA03

ATC

pravastatin; oral

3.7

33.1

152

385

R4120

NOMESCO Finland

Occupational therapy

3.7

32.9

151

383

R04.0

ICD-10 Finland

Epistaxis

3.5

32.7

162

437

J45.9

ICD-10 Finland

Asthma, unspecified

2.3

32.7

340

1453

C10AA04

ATC

fluvastatin; oral

3.1

32.6

192

590

I36.1

ICD-10 Finland

Nonrheumatic tricuspid (valve) insufficiency

160.5

32.4

AQ1

Conventional electrophysiological examination

110.1

32.3

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

4.2

32.2

129

289

C08CA05

ATC

nifedipine; systemic

4.4

32.2

124

268

I21.91

ICD-10 Finland

Myocardial infarction (acute) UNS stenosed coronary artery

+∞

32.1

FPH10

NOMESCO Finland

Open removal of transvenous cardiac pacemaker or cardioverter-defibrillator

+∞

32.1

V03AE01

ATC

polystyrene sulfonate; oral

28.9

31.8

TFC25

NOMESCO Finland

Transseptal catheterisation of left atrium or ventricle

300.0

31.7

Initial pacemaker installation

155.9

31.4

B01AE07

ATC

dabigatran etexilate; oral

6.8

31.4

112

4140B

ICD-9 Finland

Other forms of chronic ischaemic heart disease, Coronary atherosclerosis[ATHEROSCLEROSIS ARTER CORON CORDIS,AHTAUTUNUT]

+∞

31.1

FN1BE

NOMESCO Finland

Ultrasound examination of coronary arteries through catheter

+∞

31.1

WX890

NOMESCO Finland

Intesive care monitoring

44.8

31.0

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.4

30.9

302

1249

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

4.4

30.8

116

245

R4150

NOMESCO Finland

Neuropsychological rehabilitation

29.7

30.6

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

29.7

30.6

R53

ICD-10 Finland

Malaise and fatigue

2.1

30.6

376

1732

K90

ICPC

Stroke/cerebrovascular accident

14.0

30.2

41399

ICD-8 Finland

Angina pectoris, Without mention of hypertensive disease

+∞

30.1

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

8.9

30.0

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

48.5

29.9

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

3.6

29.8

142

371

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

3.1

29.8

174

531

Z94.0

ICD-10 Finland

Kidney transplant status

55.0

29.7

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

5.3

29.7

165

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

7.4

29.6

FPE40

NOMESCO Finland

Replacement of transvenous cardiac pacemaker electrode

146.6

29.5

I95.1

ICD-10 Finland

Orthostatic hypotension

9.6

29.5

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

38.7

29.4

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.7

29.4

224

809

C09AA03

ATC

lisinopril; oral

5.7

29.3

141

I21.29

ICD-10 Finland

Acute transmural myocardial infarction with other localization unspecified coronary artery status

+∞

29.1

I21.39

ICD-10 Finland

Acute transmural myocardial infarction with unspecified localization unspecified coronary artery status

+∞

29.1

5314

FHL

Bypass surgery for four or more vessels

+∞

29.1

E11

ICD-10 Finland

Type 2 diabetes mellitus

2.3

28.9

309

1333

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.2

28.9

343

1553

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

3.4

28.8

146

401

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

13.0

28.8

C07FB02

ATC

metoprolol and felodipine; systemic

11.0

28.7

PEH57

NOMESCO Finland

Bypass from femoral artery to popliteal artery below knee

276.6

28.7

E87.6

ICD-10 Finland

Hypokalaemia

6.9

28.6

100

I45.9

ICD-10 Finland

Conduction disorder, unspecified

75.7

28.5

FWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels

141.9

28.5

I20.80

ICD-10 Finland

Other angina pectoris no detected stenosis of coronary artery

141.9

28.5

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

9.0

28.4

5253

FHL

Cardiac lung machine

+∞

28.1

TFJ02

NOMESCO Finland

Muscle biopsy of heart

+∞

28.1

FPJ00

NOMESCO Finland

Revision of pacemaker pulse generator or electrode

+∞

28.1

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.9

28.1

188

627

C07AB08

ATC

celiprolol; oral

12.7

28.0

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

12.0

27.8

E66.8

ICD-10 Finland

Other obesity

6.2

27.7

115

I47.9

ICD-10 Finland

Paroxysmal tachycardia, unspecified

29.1

27.6

FN1BB

NOMESCO Finland

Contrast angiography of heart and/or coronary arteries after bypass surgery

137.3

27.5

L04AA06

ATC

mycophenolic acid; systemic

11.7

27.5

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

40.1

27.4

H3601, E113

ICD-10 Finland

12.1

27.3

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.8

27.2

541

2980

111

Conventional CABG

+∞

27.1

AA2

Off pump CABG sternotomy

+∞

27.1

FMD00

NOMESCO Finland

Replacement of aortic valve using mechanical prosthesis

+∞

27.1

I44.7

ICD-10 Finland

Left bundle-branch block, unspecified

23.9

26.9

N05CD07

ATC

temazepam; oral

2.2

26.8

314

1408

C02EA01

ATC

132.7

26.5

ATX

Other pacemaker replacement or related action, such as cord removal or replacement

91.6

26.5

C07AB05

ATC

betaxolol; oral

10.4

26.5

B03XA02

ATC

darbepoetin alfa; parenteral

9.1

26.4

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

15.6

26.3

A10AD05

ATC

insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

9.2

26.2

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

3.3

26.2

139

396

PEN23

NOMESCO Finland

Plastic repair of femoral artery

+∞

26.1

FPJ24

NOMESCO Finland

Revision of biventricular cardioverter-defibrillator with atrial and ventricular electrodes

+∞

26.1

I42.8

ICD-10 Finland

Other cardiomyopathies

+∞

26.1

FN1XT

NOMESCO Finland

Other coronary artery procedure through catheter

+∞

26.1

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

+∞

26.1

H02AB06

ATC

prednisolone; systemic

1.6

26.0

915

5950

L28

ICPC

Limited function/disability (L)

2.2

25.9

295

1306

R56.8

ICD-10 Finland

Other and unspecified convulsions

3.7

25.9

120

307

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.0

25.9

157

491

C02DE02

ATC

27.5

25.9

I95.9

ICD-10 Finland

Hypotension, unspecified

27.5

25.9

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

3.5

25.8

128

346

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

56.7

25.8

A02BC01

ATC

omeprazole; systemic

1.8

25.8

571

3250

SPAT1262

SPAT

Handing over of treatment supplies

2.0

25.7

347

1652

PAF14

NOMESCO Finland

Thrombendarterectomy of internal carotid artery

24.2

25.7

C09AA04

ATC

perindopril; oral

4.0

25.6

108

255

Z49.0

ICD-10 Finland

Preparatory care for dialysis

88.5

25.6

A10AA01

ATC

6.8

25.4

L89

ICD-10 Finland

Decubitus ulcer and pressure area

8.0

25.4

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.2

25.4

280

1221

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

5.7

25.3

122

XCK10

NOMESCO Finland

Photography of fundus of eye

2.4

25.2

234

940

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

6.4

25.2

42729

ICD-8 Finland

Symptomatic heart disease, Dissociatio cordis NUD

+∞

25.1

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

+∞

25.1

FXZ00

NOMESCO Finland

Off-pump cardiac operation

+∞

25.1

FN2CB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA) of coronary chronic total occlusion

+∞

25.1

Z49.2

ICD-10 Finland

Other dialysis

+∞

25.1

FPE96

NOMESCO Finland

Other implantation or replacement of transvenous cardiac pacemaker

+∞

25.1

C02EA03

ATC

47.3

25.0

C08CA07

ATC

nisoldipine; oral

26.7

25.0

H3603, E103

ICD-10 Finland

26.7

25.0

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

26.7

25.0

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

4.4

24.9

196

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

54.9

24.8

ZXA05

NOMESCO Finland

Left side

1.8

24.8

531

2983

M01AH05

ATC

etoricoxib; oral

0.6

24.6

711

8783

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

4.9

24.6

161

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

3.0

24.6

146

451

J81

ICD-10 Finland

Pulmonary oedema

40.5

24.3

I83.9

ICD-10 Finland

Varicose veins of lower extremities without ulcer or inflammation

5.1

24.2

144

FN2AA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), balloon only

+∞

24.1

I42.1

ICD-10 Finland

Obstructive hypertrophic cardiomyopathy

+∞

24.1

FKB10

NOMESCO Finland

Annuloplasty of mitral valve for insufficiency using ring

+∞

24.1

Z94.1

ICD-10 Finland

Heart transplant status

+∞

24.1

TFP52

NOMESCO Finland

Ablation treatment of ventricular tachycardia due to structural heart defect

+∞

24.1

I71.3

ICD-10 Finland

Abdominal aortic aneurysm, ruptured

+∞

24.1

FPE37

NOMESCO Finland

Implantation of biventricular cardioverter-defibrillator with atrial and ventricular electrodes

+∞

24.1

I44.0

ICD-10 Finland

Atrioventricular block, first degree

20.6

23.9

GD1AD

NOMESCO Finland

Thorax CT examination

3.7

23.8

108

272

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

228.5

23.7

PDQ05

NOMESCO Finland

Insertion of endovascular graft into infrarenal abdominal aorta

228.5

23.7

FPH96

NOMESCO Finland

Other removal of cardiac pacemaker or cardioverter-defibrillator

228.5

23.7

B01AB04

ATC

dalteparin; parenteral

3.8

23.7

103

250

J01DA01

ATC

[U] cefalexin; systemic

1.5

23.5

1261

9025

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

5.4

23.5

126

I42.2

ICD-10 Finland

Other hypertrophic cardiomyopathy

21.4

23.5

N05BA01

ATC

diazepam; systemic, rectal

2.1

23.2

278

1257

J96.1

ICD-10 Finland

Chronic respiratory failure

6.3

23.2

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

5.1

23.1

136

R03AC02

ATC

salbutamol; inhalant

1.6

23.1

943

6314

I21.2

ICD-10 Finland

Acute transmural myocardial infarction of other sites

+∞

23.1

196

Kela drug reimbursment

Paricalcitol and cinacalcet

+∞

23.1

41291

ICD-8 Finland

Chronic ischaemic heart disease, Status post infarctum cordis, hypertonia non indicata

+∞

23.1

4402A

ICD-9 Finland

Atherosclerosis, Of native arteries of the extremities

+∞

23.1

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.7

23.0

577

3395

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

5.7

22.9

111

AS2

Ventricular pacemaker insertion VVI (R)

219.1

22.7

C10AA02

ATC

lovastatin; oral

3.9

22.7

232

3AC01

NOMESCO Finland

12.1

22.7

K92.1

ICD-10 Finland

Melaena

3.3

22.7

117

327

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.2

22.5

240

1028

M01AE01

ATC

ibuprofen; systemic, rectal

0.6

22.4

1559

16242

C03BA11

ATC

indapamide; oral

9.0

22.3

J46

ICD-10 Finland

Status asthmaticus

6.0

22.3

QD9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in lower extremities, unspecified

42.7

22.2

315

Kela drug reimbursment

Clopidogrel

42.7

22.2

ZZA00

NOMESCO Finland

Split skin graft

4.1

22.1

206

C09DA01

ATC

losartan and diuretics; oral

2.7

22.1

158

550

AT7

Replacing the pacemaker VVI (R) S

+∞

22.1

TPX22

NOMESCO Finland

Intravenous arterial thrombolysis

+∞

22.1

I63.1

ICD-10 Finland

Cerebral infarction due to embolism of precerebral arteries

+∞

22.1

I34.9

ICD-10 Finland

Nonrheumatic mitral valve disorder, unspecified

+∞

22.1

PD5AD

NOMESCO Finland

CT of aorta

13.9

21.9

A10AD01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

8.4

21.8

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

209.9

21.7

I20.8

ICD-10 Finland

Other forms of angina pectoris

209.9

21.7

I60.9

ICD-10 Finland

Subarachnoid haemorrhage, unspecified

209.9

21.7

C08DA01

ATC

verapamil; systemic

4.8

21.7

142

K83

ICPC

Heart valve disease NOS

76.2

21.7

TQW11

NOMESCO Finland

Vacuum treatment of wound

7.3

21.6

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.7

21.6

517

2991

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

6.1

21.5

R42

ICD-10 Finland

Dizziness and giddiness

1.9

21.4

374

1954

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

4.8

21.3

141

R50.9

ICD-10 Finland

Fever, unspecified

2.1

21.1

263

1206

XF600

NOMESCO Finland

Bloodpressure measurement

3.2

21.1

117

345

N02AX02

ATC

tramadol; systemic, rectal

1.6

21.1

834

5506

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

4.5

21.1

155

Catheter ablation of arrhythmia

+∞

21.1

4111X

ICD-9 Finland

Other acute and subacute forms of ischaemic heart disease, Intermediate coronary syndrome[PITKITTYNYT ANGINA PECTORIS -KOHTAUS,MÄÄRITTELEMÄT]

+∞

21.1

FNG10

NOMESCO Finland

Embolectomy of coronary artery

+∞

21.1

V03AE02

ATC

sevelamer; oral

+∞

21.1

E66.01

ICD-10 Finland

Obesity due to excess calories

3.7

21.1

234

C09CA06

ATC

candesartan; oral

1.9

20.9

324

1620

G47.3

ICD-10 Finland

Sleep apnoea

1.8

20.9

383

2031

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

3.1

20.9

121

368

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

200.7

20.8

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

73.1

20.8

C09DA03

ATC

valsartan and diuretics; oral

4.4

20.7

166

137

Kela drug reimbursment

Uraemia requiring dialysis

105.0

20.7

A06AD11

ATC

lactulose; oral

2.0

20.7

307

1511

N17.8

ICD-10 Finland

Other acute renal failure

12.0

20.6

R60.0

ICD-10 Finland

Localized oedema

2.4

20.5

187

741

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

12.6

20.4

N03AX16

ATC

pregabalin; oral

1.8

20.4

416

2287

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.8

20.3

373

1980

B01AF01

ATC

rivaroxaban; oral

2.4

20.3

181

713

K29

ICPC

Cardiovascular sympt/complt other

3.9

20.2

206

N03AX14

ATC

levetiracetam; systemic

4.8

20.1

134

ZST00

NOMESCO Finland

Procedure related to previous procedure classified in chapter T

+∞

20.1

FNE20

NOMESCO Finland

Coronary bypass using free arterial graft of radial artery

+∞

20.1

4340A

ICD-9 Finland

Occlusion of cerebral arteries, Cerebral thrombosis

+∞

20.1

I63.0

ICD-10 Finland

Cerebral infarction due to thrombosis of precerebral arteries

+∞

20.1

B05DB

ATC

Hypertonic solutions

+∞

20.1

B05DA

ATC

Isotonic solutions

+∞

20.1

J01MA14

ATC

moxifloxacin; systemic

2.4

19.9

183

730

J01DB01

ATC

cefalexin; oral

1.5

19.9

1666

12935

I71.9

ICD-10 Finland

Aortic aneurysm of unspecified site, without mention of rupture

70.1

19.8

F05.9

ICD-10 Finland

Delirium, unspecified

6.6

19.8

B01AC22

ATC

prasugrel; oral

191.5

19.8

PEH56

NOMESCO Finland

Bypass from femoral to popliteal artery above knee

191.5

19.8

I74.3

ICD-10 Finland

Embolism and thrombosis of arteries of lower extremities

100.4

19.7

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

100.4

19.7

K74

ICPC

Ischaemic heart dis with angina

19.6

19.7

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

3.8

19.6

207

WX725

NOMESCO Finland

Noninvasive ventilation

3.3

19.4

101

285

TPX10

NOMESCO Finland

Implantation of vascular injection port

4.3

19.3

157

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

6.6

19.1

AB2

AVR bio, stent

+∞

19.1

PE1YT

NOMESCO Finland

Femoral or popliteal artery PTA with stent

+∞

19.1

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

+∞

19.1

ASB

Insertion of a biventricular physiological pacemaker DDD (R)

+∞

19.1

Z95.8

ICD-10 Finland

Presence of other cardiac and vascular implants and grafts

+∞

19.1

E86

ICD-10 Finland

Volume depletion

6.0

19.0

I34.0

ICD-10 Finland

Mitral (valve) insufficiency

21.3

18.9

PD1BD

NOMESCO Finland

Extensive CT of abdominal aorta and branches

21.3

18.9

B01AF03

ATC

edoxaban; oral

67.0

18.8

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.8

18.8

367

1983

WX870

NOMESCO Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

521

683

7.74

317.25

5.1

1.7

ng/l

356.3

60.5

24.00

491

602

(3012095) Magnesium [Moles/volume] in Serum or Plasma

884

1970

5.06

313.50

5.6

3.2

mmol/l

0.8

0.25

835

1806

(3027801) Oxygen [Partial pressure] in Arterial blood

688

1232

5.94

311.05

14.5

6.2

kpa

11.8

13.3

7.20

654

1166

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

688

1232

5.94

311.05

14.5

6.2

kpa

5.2

5.1

1.65

657

1164

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

582

723

8.36

307.65

3.4

1.5

ug/l

19.3

4.4

7.37

532

578

(3020779) Urea [Moles/volume] in Serum or Plasma

713

816

9.56

307.65

11.0

3.9

mmol/l

10.1

8.8

3.20

683

767

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

315

135

22.34

307.65

5.3

2.1

u/ml

0.3

0.78

223

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1224

2982

5.28

307.65

5.2

1.6

ng/l

3053.9

454.4

26.49

1116

2344

(3003458) Phosphate [Moles/volume] in Serum or Plasma

745

1458

5.52

305.83

8.9

3.6

mmol/l

1.1

1.0

8.97

698

1341

(3003396) Base excess in Arterial blood by calculation

681

1231

5.87

304.44

14.6

6.2

mmol/l

0.9

0.08

544

927

(3016502) Oxygen saturation in Arterial blood

628

1074

6.10

296.91

15.4

6.7

95.3

96.2

2.32

609

1024

(3002173) Hemoglobin [Mass/volume] in Arterial blood

567

997

5.81

258.54

16.2

7.1

g/l

119.1

124.4

5.99

555

945

(3022217) INR in Platelet poor plasma by Coagulation assay

609

1150

5.47

257.11

33.5

4.1

inr

1.8

1.1

13.54

230

(3032080) INR in Blood by Coagulation assay

1433

5328

3.52

240.92

17.7

2.9

inr

1.5

1.1

28.97

386

1403

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

823

2179

4.10

227.17

7.0

2.1

ng/l

1458.2

184.4

5.71

763

1594

(3018677) aPTT in Platelet poor plasma by Coagulation assay

653

1455

4.66

225.45

3.7

1.6

32.2

28.8

13.57

631

1411

(3027456) Digoxin [Moles/volume] in Serum or Plasma

129

42.96

190.90

2.6

2.1

nmol/l

1.0

0.9

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

623

1514

4.21

190.21

4.1

1.6

20.9

26.4

15.62

537

1262

(3004789) Transferrin [Mass/volume] in Serum or Plasma

650

1663

4.02

184.71

3.8

1.6

g/l

2.2

2.3

1.89

610

1514

(3000991) Gas panel - Venous blood

452

872

5.08

183.20

17.1

6.5

—

(3023368) Bacteria identified in Blood by Culture

1075

3906

3.13

176.58

5.8

3.5

—

(3019060) Gas panel - Arterial blood

383

666

5.53

173.86

10.2

4.5

—

(3022948) Iron [Moles/volume] in Serum or Plasma

666

1822

3.76

171.10

3.8

1.7

umol/l

11.4

14.7

25.24

630

1650

(3014111) Lactate [Moles/volume] in Serum or Plasma

460

965

4.67

168.24

15.0

5.8

mmol/l

1.7

1.3

3.66

437

928

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

355

595

5.69

167.38

19.8

8.4

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

241

266

8.40

166.49

1.9

1.8

ug/l

30.0

23.0

0.91

232

258

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

266

338

7.34

163.42

3.1

1.8

ug/l

747.6

603.9

0.27

253

308

(3014576) Chloride [Moles/volume] in Serum or Plasma

580

1505

3.87

159.96

15.3

5.9

mmol/l

104.5

104.6

0.03

573

1469

(3008152) Bicarbonate [Moles/volume] in Arterial blood

355

649

5.21

151.91

15.0

6.0

mmol/l

24.1

24.6

0.86

338

580

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

338

593

5.41

151.34

17.5

7.6

mmol/l

24.0

24.3

0.48

320

555

(3021447) Carbon dioxide [Partial pressure] in Venous blood

431

1003

4.15

136.86

6.4

2.6

kpa

6.0

5.8

3.17

403

973

(3002032) Base excess in Venous blood by calculation

431

1008

4.13

135.92

6.4

2.6

mmol/l

1.8

0.04

345

786

(3023183) Ammonium ion [Moles/volume] in Plasma

186

209

8.11

126.23

2.2

2.0

umol/l

33.9

38.4

0.41

155

165

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

995

4067

2.66

123.73

2.9

1.8

u/l

276.8

217.9

1.14

943

3726

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1172

5234

2.52

120.77

6.1

2.1

ng/l

244.2

22.0

2.07

982

3480

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

261

482

5.01

109.52

6.6

2.9

mmol/l

23.9

24.1

0.41

232

433

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

173

222

7.06

104.75

4.3

2.6

g/l

3.5

3.6

0.07

166

210

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

291

613

4.42

104.17

13.7

6.1

mmol/l

24.9

24.7

0.44

286

606

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

165

203

7.35

103.64

5.7

2.1

82.9

89.5

2.25

160

189

(3036489) Thrombin time

177

237

6.77

103.13

4.2

2.0

23.0

20.7

3.22

164

212

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

616

2160

2.83

100.60

2.2

1.6

—

(3024354) Oxygen [Partial pressure] in Venous blood

336

840

3.75

95.31

5.6

2.4

kpa

4.7

4.5

0.36

309

813

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

149

182

7.37

94.10

4.4

2.6

231.5

187.2

4.49

139

172

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

235

471

4.58

89.19

2.5

1.7

ug/l

3.8

2.3

0.42

205

412

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

444

1382

3.07

89.01

2.0

1.5

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

818

3479

2.41

88.90

2.8

1.8

mg/l

3.2

2.7

6.28

709

2823

(3013826) Glucose [Moles/volume] in Serum or Plasma

1611

9121

2.12

85.78

11.4

3.2

mmol/l

7.5

6.6

34.30

1530

8374

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

437

1396

2.99

83.45

2.0

1.5

—

(3007853) Bacteria identified in Skin by Aerobe culture

472

1600

2.83

80.79

2.5

1.5

—

(3024928) Oxygen saturation in Venous blood

135

177

6.83

80.02

4.8

2.6

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

260

646

3.70

73.90

6.2

2.4

g/l

122.9

133.1

8.98

245

636

(3047181) Lactate [Moles/volume] in Blood

177

334

4.79

72.00

13.1

6.2

mmol/l

1.7

1.2

2.22

157

286

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

107

127

7.49

69.13

8.7

6.2

mg/l

12.2

11.5

0.65

115

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

221

514

3.92

68.86

1.9

1.6

g/l

1.6

1.5

0.39

190

411

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

308

893

3.20

68.85

1.9

1.5

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1446

8354

1.95

66.71

8.1

6.0

umol/l

13.8

11.7

4.43

1389

7879

(3006576) Bicarbonate [Moles/volume] in Blood

30.64

66.57

8.0

3.7

mmol/l

24.7

23.3

0.67

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1304

7307

1.95

65.48

14.6

4.2

mmol/l

1.2

52.25

1208

6357

(3042936) Bacteria identified in Isolate by Culture

502

1939

2.48

65.28

2.9

1.7

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

207

482

3.90

64.33

11.3

4.9

1.7

1.5

2.24

194

449

(3027945) Reticulocytes/100 erythrocytes in Blood

436

1591

2.59

63.75

2.7

2.4

1.9

1.5

12.08

389

1364

(3007930) Methemoglobin/Hemoglobin.total in Blood

201

469

3.89

62.26

11.7

5.0

1.1

0.9

0.75

187

435

(3010813) Leukocytes [#/volume] in Blood

2097

21340

0.49

61.87

41.0

14.6

e9/l

7.5

6.5

56.63

2004

20360

(3035941) MCH [Entitic mass]

2096

21328

0.49

61.63

40.8

14.5

30.4

30.5

1.48

2029

20793

(3026361) Erythrocytes [#/volume] in Blood

2097

21332

0.49

61.50

40.9

14.6

e12/l

4.3

4.6

84.56

2002

20358

(3000963) Hemoglobin [Mass/volume] in Blood

2098

21337

0.49

61.42

41.3

14.7

g/l

128.9

138.5

109.25

2026

20789

(3024731) MCV [Entitic volume]

2097

21330

0.49

61.41

40.8

14.6

92.0

91.4

7.76

2030

20794

(3033658) Prothrombin time (PT) actual/Normal

797

3822

2.08

61.33

6.7

3.0

78.8

93.0

39.27

775

3740

(3007461) Platelets [#/volume] in Blood

2096

21318

0.50

61.18

40.9

14.6

e9/l

233.8

242.6

7.05

2014

20426

(3018572) Chloride [Moles/volume] in Blood

136

238

5.11

60.23

15.3

7.6

mmol/l

105.5

104.8

0.65

125

207

(3039000) Anion gap in Blood

136

238

5.11

60.23

15.3

7.6

mmol/l

11.5

0.00

125

207

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

584

2501

2.26

59.66

3.2

1.4

mg/l

3.0

1.2

4.82

478

1871

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1372

8027

1.87

58.34

14.9

4.7

mmol/l

1.2

45.07

1174

6635

(3020891) Body temperature

182

419

3.92

57.38

11.3

3.8

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

261

796

3.00

53.17

6.3

2.3

ng/l

141.3

65.9

14.07

226

670

(3015235) Bicarbonate [Moles/volume] in Capillary blood

135

262

4.60

53.00

4.9

2.2

mmol/l

24.4

24.8

0.46

123

222

(3028626) Oxygen [Partial pressure] in Capillary blood

127

236

4.80

52.49

6.0

2.8

kpa

8.2

8.1

0.11

118

215

(3009343) pH of Capillary blood

253

774

2.98

51.22

7.0

2.8

7.4

1.54

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

231

671

3.13

51.11

1.7

1.4

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

427

1701

2.36

51.05

4.7

4.5

u/l

273.1

240.5

3.96

400

1601

(3024561) Albumin [Mass/volume] in Serum or Plasma

1191

6872

1.82

50.92

7.0

3.9

g/l

32.5

35.6

49.36

1114

6237

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

255

792

2.94

50.24

7.1

2.8

kpa

5.1

0.00

241

728

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

245

750

2.98

49.51

7.1

2.8

mmol/l

2.0

1.6

0.60

181

563

(3027273) Bicarbonate [Moles/volume] in Venous blood

202

551

3.31

49.49

6.0

2.3

mmol/l

25.0

25.2

0.30

188

536

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

886

4711

1.88

48.80

3.7

2.9

u/l

80.5

36.8

2.14

839

4417

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

121

230

4.68

48.69

1.4

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

121

230

4.68

48.69

1.4

1.2

—

(3044640) Blood type and Crossmatch panel - Blood

937

5103

1.85

47.63

3.6

2.1

—

(3042733) HLA Ab [Presence] in Serum

23.67

47.50

5.4

4.2

—

(3023419) Bacteria identified in Sputum by Culture

104

179

5.15

46.88

2.1

2.7

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1035

5836

1.80

46.79

4.2

2.1

ug/l

189.8

168.2

1.16

973

5221

(1616796) Gas panel - Central venous blood

111

205

4.81

46.20

5.0

1.9

—

(3010421) pH of Blood

125

259

4.30

45.24

5.9

2.8

7.4

0.81

106

212

(3027315) Oxygen [Partial pressure] in Blood

111

219

4.50

42.70

5.5

2.9

kpa

8.5

8.6

0.36

106

212

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2027

20329

0.57

41.85

14.7

8.2

u/l

32.7

25.6

10.36

1935

19204

(3013290) Carbon dioxide [Partial pressure] in Blood

110

219

4.45

41.84

5.5

2.9

kpa

5.0

0.43

105

212

(3012501) Base excess in Blood by calculation

110

219

4.45

41.84

5.5

2.9

mmol/l

2.7

2.2

0.92

146

(3021901) Oxygen saturation in Capillary blood

175

4.90

41.48

3.7

2.0

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1858

19048

0.58

41.30

5.8

4.3

mmol/l

2.2

2.9

180.17

1697

16893

(3023520) Reticulocytes [#/volume] in Blood

311

1190

2.40

40.27

3.1

2.6

e9/l

70.4

63.4

2.37

240

927

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1798

18544

0.59

40.03

5.3

3.9

mmol/l

4.0

4.9

184.27

1656

16532

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1778

18381

0.59

39.79

5.3

3.9

mmol/l

1.3

1.5

98.86

1638

16293

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

201

624

2.90

39.48

4.1

3.2

pmol/l

4.1

4.6

8.97

181

543

(3026008) Bacteria identified in Urine by Culture

788

4285

1.79

38.86

3.4

2.7

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

10.05

37.53

10.1

1.1

mg/l

60.4

76.7

0.91

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

730

3915

1.80

37.51

3.4

2.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

65.65

37.38

10.1

6.7

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1802

18436

0.61

36.22

5.2

4.1

mmol/l

6.4

5.9

27.43

1623

16241

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

118

277

3.78

36.14

1.7

1.6

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1752

18039

0.61

36.05

26.2

9.4

ml/min/173m2

72.0

79.9

30.50

1528

14259

(40767503) Oxygen content in Capillary blood by calculation

205

4.22

35.04

3.7

1.7

16.0

16.6

0.65

(3018418) pH of Serum or Plasma

806

4539

1.72

34.52

6.9

3.1

7.4

0.91

172

786

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

118

289

3.62

34.01

1.7

1.6

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

212

4.04

32.76

2.0

1.2

u/ml

149.8

99.6

0.75

(3051651) Icteric interference index of Serum or Plasma

7.51

32.17

6.6

3.2

—

(42870588) Differential panel, method unspecified - Blood

906

5363

1.65

31.68

7.0

5.4

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

103

246

3.70

30.79

2.0

1.3

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

122

327

3.31

30.67

1.4

1.2

—

(3003434) Protein [Mass/volume] in Pleural fluid

145

4.61

30.47

1.5

1.2

g/l

26.5

38.5

9.05

135

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

705

8794

0.60

30.29

3.8

4.5

23.0

21.1

2.29

303

4696

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

475

6566

0.55

30.00

2.6

3.3

ug/l

0.7

0.8

3.19

326

4593

(4306422)

6.46

29.35

1.3

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

6.46

29.35

1.3

1.0

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1195

7676

1.57

29.18

5.4

3.4

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

353

1614

2.00

28.98

5.0

2.6

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

102

255

3.53

28.54

2.8

1.5

g/l

128.1

133.1

1.01

163

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

312

1375

2.07

28.31

2.4

2.3

g/l

0.2

2.51

283

1295

(3038071) Oxygen [Partial pressure] in Mixed venous blood

50.82

28.10

10.5

6.7

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

100

5.25

28.05

1.6

1.2

promille

1.1

1.4

0.56

(3028271) Lactate [Moles/volume] in Capillary blood

159

4.26

28.02

2.4

1.4

mmol/l

1.9

1.7

0.37

153

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

948

10883

0.64

27.63

4.2

5.5

ug/l

2.5

4.0

1.93

819

9717

(44790049)

122

4.74

27.49

1.8

1.3

—

(44806118)

122

4.74

27.49

1.8

1.3

—

(44790047)

122

4.74

27.49

1.8

1.3

—

(44790048)

122

4.74

27.49

1.8

1.3

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

294

1287

2.07

27.12

2.2

1.4

—

(3019309) Folate [Moles/volume] in Red Blood Cells

594

3261

1.71

27.01

1.9

1.6

nmol/l

1190.3

1092.9

1.61

460

2303

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

7.08

26.89

1.3

1.1

88.0

100.0

1.64

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

5.65

26.79

1.5

1.2

u/ml

4.5

5.0

0.09

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

109

297

3.24

26.71

2.7

1.7

mg/l

11.1

10.4

0.36

102

284

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

170

4.03

26.48

1.6

1.3

—

(40758558) Short blood count panel - Blood

708

4106

1.64

25.98

8.5

6.6

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

119

355

2.97

25.06

1.9

1.6

—

(3004451) EKG impression Narrative

9.63

24.61

1.4

1.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

205

3.60

24.38

1.6

1.2

—

(3022096) Basophils/100 leukocytes in Blood

1114

7257

1.51

24.24

7.5

5.5

0.6

0.7

3.68

1052

6624

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

5.16

23.94

1.5

1.2

u/ml

2.3

9.5

0.57

(3022313) Gas panel - Capillary blood

166

606

2.44

23.63

7.9

3.0

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

335

1614

1.89

23.38

3.1

2.7

umol/l

10.4

9.0

0.62

293

1428

(3052851) Hemolysis interference index of Serum or Plasma

120

375

2.83

23.27

6.2

2.7

—

(3020630) Protein [Mass/volume] in Serum or Plasma

263

1170

2.03

23.14

2.2

2.6

g/l

63.9

67.2

7.74

244

1046

(3020682) Albumin/Creatinine [Ratio] in Urine

769

4662

1.57

23.02

4.3

3.4

mg/mmol

21.0

3.4

6.51

520

2722

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

107

316

2.99

22.95

5.1

2.9

mg/l

2.0

1.2

11.92

290

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

153

3.95

22.92

1.5

1.3

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

811

4983

1.55

22.85

3.3

2.3

u/l

65.2

60.8

0.51

767

4543

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

+∞

22.64

12.0

0.0

mmol/l

4.9

—

(3012516) Albumin [Mass/volume] in Urine

735

4427

1.57

22.57

3.5

2.8

mg/l

369.8

481.5

0.28

498

2586

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1768

17571

0.68

22.52

5.0

3.5

mmol/l

1.4

1.2

7.73

1627

15399

(3006504) Eosinophils/100 leukocytes in Blood

1133

7496

1.48

22.37

7.6

5.4

2.8

3.0

1.00

1066

6827

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

9.00

21.97

1.1

1.2

—

(3001604) Monocytes [#/volume] in Blood

1182

7915

1.47

21.81

7.2

5.2

e9/l

0.7

0.6

11.77

1034

6710

(3006315) Basophils [#/volume] in Blood

1190

7985

1.47

21.69

7.1

5.2

e9/l

0.0

0.49

1042

6764

(3019069) Monocytes/100 leukocytes in Blood

1136

7558

1.47

21.60

7.9

5.7

9.1

8.8

1.54

1071

6910

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

46.92

21.51

7.2

7.4

—

(40761511) CBC panel - Blood by Automated count

2015

19475

0.67

21.40

27.9

9.3

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

148

541

2.43

21.02

1.3

1.5

u/ml

17.8

18.3

—

(3024932) HLA-DR beta [Type]

9.82

20.92

1.1

1.2

—

(3019198) Lymphocytes [#/volume] in Blood

1210

8187

1.46

20.90

7.2

5.3

e9/l

1.8

2.0

2.77

1065

7061

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

164

3.69

20.84

1.6

1.3

—

(1761868) Lipid panel - Serum or Plasma

482

6153

0.61

20.71

3.7

2.6

—

(3009508) Creatinine [Moles/volume] in Urine

754

4649

1.53

20.55

3.5

2.7

mmol/l

6.9

8.4

18.34

623

3773

(3024471) HLA-A [Type]

9.41

20.32

1.0

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

142

518

2.43

20.26

2.5

1.7

u/l

37.7

41.2

0.88

110

477

(3023103) Potassium [Moles/volume] in Serum or Plasma

2082

19942

0.67

20.25

38.5

10.4

mmol/l

4.1

4.0

23.32

2007

19096

(3051611) Lipemic interference index of Serum or Plasma

117

4.18

20.14

6.5

2.6

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

302

1478

1.85

19.97

2.2

1.4

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

191

799

2.13

19.75

1.9

1.5

—

(3013115) Eosinophils [#/volume] in Blood

1213

8275

1.44

19.70

7.9

5.4

e9/l

0.2

0.89

1063

7096

(3000850) Epithelial cells [#/volume] in Urine

586

3446

1.58

19.62

3.3

2.2

e6/l

5.4

3.8

1.98

526

2937

(3026493) Urate [Moles/volume] in Serum or Plasma

658

3977

1.54

19.50

3.4

2.2

umol/l

4405.7

5665.9

0.32

557

3400

(3002030) Lymphocytes/100 leukocytes in Blood

1146

7778

1.44

18.92

7.7

5.5

23.7

28.4

35.07

1079

7065

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

6.38

18.88

1.2

2.0

umol/l

176.7

135.6

0.10

(3012441) Differential panel - Pleural fluid

127

3.92

18.86

1.5

1.3

—

(3026782) Osmolality of Urine

556

3257

1.58

18.85

3.5

2.3

mosm/kgh2o

530.5

599.0

10.97

487

2698

(3023199) Leukocytes [#/volume] in Pleural fluid

147

3.69

18.82

1.6

1.3

e6/l

2179.6

2936.1

0.23

110

(3019550) Sodium [Moles/volume] in Serum or Plasma

2080

19856

0.68

18.78

38.4

10.4

mmol/l

139.0

139.9

33.27

2006

19051

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

216

3.17

18.69

1.7

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

351

1846

1.72

18.14

2.2

1.5

—

(3018010) Neutrophils/100 leukocytes in Blood

1127

7671

1.43

18.08

7.6

5.3

60.4

56.5

20.88

1060

7027

(3028308) Erythrocytes [#/volume] in Pleural fluid

136

3.73

17.90

1.5

1.3

e6/l

36506.2

75805.0

0.60

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

224

3.05

17.61

1.7

1.6

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

225

1055

1.91

16.94

2.2

2.5

nmol/l

358.3

381.3

0.95

208

981

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

230

2.97

16.85

1.6

1.2

—

(4268621)

5.63

16.75

2.9

2.1

—

(3017569) Oxygen content in Arterial blood

5.99

16.73

1.8

3.3

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

294

2.72

16.65

1.3

1.1

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

209

3.06

16.59

1.6

1.2

u/ml

323.5

254.3

0.91

123

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

297

2.69

16.34

1.7

1.4

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

4.21

16.08

1.3

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

331

2.58

15.96

1.5

1.2

—

(3019977) pH of Arterial blood

5.19

15.86

3.5

2.7

7.4

0.03

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

114

425

2.36

15.56

1.6

1.5

titre

72.0

202.5

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

4.03

15.22

2.5

2.6

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

269

1378

1.75

15.19

3.0

2.3

u/l

68.5

43.1

0.34

230

1191

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

6.78

15.14

2.5

2.8

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1458

0.37

14.94

2.2

1.8

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

3.91

14.62

1.3

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

4.19

14.58

1.1

1.0

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

134

550

2.15

14.58

8.7

3.0

mmol/l

24.7

24.9

0.33

125

509

(3051593) INR in Capillary blood by Coagulation assay

9.15

14.54

8.9

1.0

—

(40768446) Kidney Pathology biopsy report

10.52

14.26

2.3

1.6

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

188

880

1.90

14.23

1.5

1.4

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

164

3.14

14.13

1.5

1.2

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

103

386

2.35

13.92

2.7

3.4

ratio

2.7

4.9

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

131

3.39

13.84

1.6

1.4

—

(3009542) Hematocrit [Volume Fraction] of Blood

1744

16843

0.74

13.45

33.5

10.9

37.8

40.1

15.52

1121

11548

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

174

3.01

13.40

4.0

2.3

u/ml

230.4

522.3

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1787

17193

0.74

13.39

7.4

4.7

mmol/mol

43.3

38.6

34.29

1648

15337

(40768806) Pleura Pathology biopsy report

134

3.32

13.37

1.5

1.6

—

(3002582) Erythrocytes [#/volume] in Urine

783

5218

1.40

13.28

4.0

2.8

e6/l

262.9

71.3

0.89

648

3929

(3035880) pH of Pleural fluid

4.92

13.24

1.2

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

104

401

2.28

13.19

2.7

3.4

mg/l

54.2

29.6

1.70

340

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

122

503

2.14

13.15

3.0

2.6

—

(3011648) Oxygen content in Venous blood

4.48

13.09

2.8

3.9

9.6

11.2

1.36

(40760888) Immunoglobulin light chains.free panel - Serum

301

2.47

13.02

2.1

3.6

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

235

2.68

12.99

12.9

4.1

iu/ml

8970.0

316.0

0.70

(3034860) Kappa light chains.free [Mass/volume] in Serum

104

404

2.26

12.96

2.7

3.4

mg/l

61.8

40.8

1.32

341

(3034426) Prothrombin time (PT)

9.89

12.89

1.9

1.2

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

1310

9499

1.33

12.81

10.1

8.4

e9/l

4.6

4.0

18.33

1157

8188

(3048929) Epstein Barr virus Ab [Presence] in Serum

330

2.39

12.79

1.5

1.2

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

3.72

12.75

1.4

1.3

nmol/l

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

199

2.81

12.66

1.3

1.2

—

(3045788) Cell count panel - Pleural fluid

109

3.51

12.63

1.6

1.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

308

2.42

12.41

1.9

1.6

—

(3028026) IgM [Mass/volume] in Serum or Plasma

156

721

1.91

12.29

1.5

2.1

g/l

1.3

1.8

1.40

140

649

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

129

3.24

12.17

1.6

1.9

—

(3030467) Casts [#/volume] in Urine by Automated count

717

4783

1.38

11.88

3.9

2.7

e6/l

0.6

0.3

2.62

589

3507

(21494755) Public health laboratory ask at order entry panel

1364

0.43

11.52

1.3

1.4

—

(40768804) Tissue Pathology biopsy report

711

7713

0.73

11.52

2.2

2.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

881

9255

0.75

11.50

2.7

2.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

143

3.05

11.48

1.6

1.8

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

971

0.34

11.21

2.0

1.5

—

(3004588) Protein electrophoresis panel - Serum or Plasma

193

981

1.74

11.20

2.0

2.4

—

(36304419) Bacteria [Presence] in Urine

690

4614

1.37

11.17

3.8

2.6

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

132

3.10

11.13

1.3

1.1

u/l

50.2

64.6

0.84

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

3.93

11.12

1.3

1.2

u/l

46.2

22.0

0.89

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

3.84

11.10

1.9

1.4

umol/l

14.5

12.7

0.78

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

129

589

1.93

10.58

2.3

1.5

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

8.11

10.50

1.0

1.3

mmol/l

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

106

3.28

10.41

1.2

1.0

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

138

648

1.87

10.40

2.4

1.7

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

120

3.12

10.31

2.8

2.4

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

7.29

10.30

1.3

1.1

—

(40768800) Prostate Pathology biopsy report

906

0.34

10.30

1.1

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

140

2073

0.56

10.08

2.0

nmol/l

12.0

13.4

1.22

119

1844

(3005719) IgG [Mass/volume] in Serum or Plasma

185

958

1.71

10.06

2.1

2.6

g/l

10.3

10.7

0.41

167

870

(3037522) Nuclear Ab [Titer] in Serum

296

1721

1.53

10.05

1.3

titre

343.7

607.5

3.36

341

(3003181) Sodium [Moles/volume] in Urine

187

2.61

9.75

2.7

1.2

mmol/l

63.0

73.2

0.71

151

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

3.42

9.72

1.2

u/l

8.8

16.8

3.46

(3040151) Glucose [Moles/volume] in Capillary blood

120

3.04

9.70

9.2

3.1

mmol/l

8.4

7.2

1.17

(3052592) Norovirus Ag [Presence] in Stool

6.13

9.43

1.5

1.4

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

3.62

9.08

1.1

—

(3012565) Volume of 24 hour Urine

4.43

9.07

2.9

2.8

1229.7

2065.0

2.35

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

3.23

8.96

1.5

1.4

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

3.33

8.86

1.3

pmol/l

251.6

237.6

0.07

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

171

2.60

8.84

6.9

1.8

—

(3018095) Leukocytes [#/volume] in Urine

839

5945

1.30

8.83

4.5

3.1

e6/l

204.9

97.1

1.17

666

4184

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

118

2.95

8.78

1.2

1.0

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

6.49

8.75

1.3

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

219

2.39

8.73

4.4

4.7

umol/l

350.3

366.9

0.38

177

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

263

2.26

8.68

2.3

1.8

ug/min

186.3

68.3

1.47

141

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

9.51

8.56

1.1

1.3

12.0

16.6

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

218

1232

1.57

8.41

6.6

3.0

mmol/l

1.2

7.21

195

1026

(3044242) Glucose [Moles/volume] in Arterial blood

3.92

8.16

1.3

2.9

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

328

2.08

8.12

1.2

1.5

g/l

1.2

0.13

306

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

361

2.01

7.90

2.2

2.3

g/l

0.0

0.00

339

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

311

2.08

7.73

1.1

1.5

g/l

0.2

0.93

289

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

109

525

1.82

7.67

2.2

2.3

g/l

10.0

10.5

0.60

417

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

3.27

7.60

1.6

1.2

—

(4198724)

4.45

7.56

4.8

1.2

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

7.92

7.52

1.2

1.3

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

3.09

7.44

2.0

1.5

u/l

8.0

7.2

0.06

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

114

563

1.77

7.40

2.2

2.3

g/l

3.7

3.8

0.25

387

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

224

2769

0.67

7.39

4.8

4.1

33.0

31.7

0.85

178

1596

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

114

564

1.77

7.35

2.2

2.3

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

114

564

1.77

7.35

2.2

2.3

g/l

7.5

7.0

1.66

415

(3004809) Band form neutrophils/100 leukocytes in Blood

238

2.20

7.27

2.4

3.6

1.7

1.6

0.04

173

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

373

1.94

7.23

2.2

g/l

0.0

0.00

340

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

117

2.75

7.23

1.6

1.8

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

117

2.75

7.23

1.6

1.8

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

117

2.75

7.23

1.6

1.8

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

208

2.26

7.03

1.1

1.3

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

150

2.49

6.95

3.2

1.6

—

(3021960) Folate [Moles/volume] in Serum or Plasma

568

3937

1.30

6.84

1.8

1.4

nmol/l

18.4

21.2

4.60

510

3207

(3039443) Prostate specific Ag panel - Serum or Plasma

623

0.37

6.73

1.6

—

(3028707) Methadone [Presence] in Urine by Screen method

137

2.54

6.72

3.5

2.2

—

(3008037) Lactate [Moles/volume] in Venous blood

300

2.00

6.63

5.1

1.9

mmol/l

2.0

1.5

2.85

293

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

990

7359

1.24

6.59

2.3

1.8

pmol/l

93.2

95.7

0.94

541

3743

(3003338) MCHC [Mass/volume]

1649

15475

0.82

6.58

37.3

12.8

g/l

330.3

333.5

31.80

1606

15332

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

3.17

6.55

1.3

1.4

—

(3037756) Immunofixation for Serum or Plasma

272

2.05

6.55

1.4

1.8

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1723

16094

0.82

6.53

5.2

3.9

mu/l

2.2

2.3

0.38

1554

14012

(3007566) Smooth muscle Ab [Titer] in Serum

296

2.00

6.52

1.1

1.2

titre

122.5

57.5

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

406

1.85

6.50

2.1

2.2

g/l

0.0

0.1

0.87

373

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

2.83

6.44

1.9

1.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

3.13

6.41

1.3

1.4

—

(3044927) Protein electrophoresis panel - Urine

131

2.52

6.32

1.3

1.2

—

(3021589) Normoblasts [#/volume] in Blood

999

7471

1.23

6.20

14.7

7.5

e9/l

0.0

0.59

823

6071

(21494890) Protein electrophoresis panel - 24 hour Urine

118

2.57

6.10

1.2

2.6

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

227

2.11

6.10

1.3

u/l

33.1

38.2

0.14

187

(3004775) Volume in Urine collected for unspecified duration

2.96

5.88

2.2

1.6

690.5

629.0

0.28

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

442

4737

0.77

5.86

1.8

1.5

mmol/l

1.4

1.3

2.60

380

3869

(3026480) Teichoate Ab [Titer] in Serum

15.55

5.76

1.2

1.0

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

198

2.15

5.75

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

111

1504

0.62

5.66

1.4

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

4.48

5.65

1.3

1.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

445

1.75

5.62

2.1

g/l

35.4

39.2

5.50

361

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

6.17

5.55

1.1

1.0

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

266

1.96

5.52

3.6

3.5

61.2

55.4

2.13

266

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

2.79

5.50

1.3

—

(3025941) Bacteria identified in Stool by Culture

133

745

1.56

5.43

1.3

1.2

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

103

542

1.66

5.42

2.2

2.3

g/l

3.3

2.9

2.62

402

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

212

2.05

5.22

1.1

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

5.76

5.21

1.1

1.2

u/l

23.6

293.9

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

3.02

5.18

2.0

1.6

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

268

1734

1.36

5.17

1.9

1.7

1.8

1.5

5.63

221

1508

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

2.85

5.10

1.6

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

2.85

5.10

1.6

—

(40757373) Influenza virus identified in Isolate

4.32

5.03

1.3

1.4

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

252

1.93

4.97

3.4

3.2

e9/l

4.8

3.9

1.90

252

(3000093) Morphology [Interpretation] in Blood Narrative

131

2.32

4.96

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

253

1.92

4.92

4.1

1.7

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

+∞

4.92

2.0

0.0

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

3.09

4.89

1.4

1.6

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

3.09

4.89

1.4

1.6

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

199

1237

1.41

4.88

3.8

2.3

ml/min/173m2

51.0

72.8

13.47

106

412

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

2.65

4.86

2.1

1.4

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

4.16

4.81

1.1

1.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

4.16

4.81

5.1

1.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

4.16

4.81

5.1

1.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

493

1.65

4.80

2.2

2.3

g/l

1.1

1.4

0.31

410

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1742

13938

1.18

4.74

10.1

6.3

u/l

88.5

78.0

9.24

1662

12895

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

271

1.86

4.63

1.1

1.3

miu/ml

82.7

217.3

3.76

120

(3042631) Mycobacterium sp identified in Specimen

193

2.02

4.59

2.3

2.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

603

0.48

4.51

1.2

1.6

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

4.53

4.49

1.7

1.1

g/l

30.2

20.9

—

(3000492) Spirometry study

223

1438

1.36

4.42

1.8

1.5

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

3.67

4.42

1.1

1.2

ratio

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

215

1.94

4.36

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

4.80

4.35

1.1

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

398

2794

1.26

4.25

3.2

2.7

e6/l

3.0

1.7

1.81

243

1516

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

409

1.66

4.24

1.2

1.1

—

(3033799) Differential panel - Peritoneal fluid

3.99

4.22

2.3

1.5

—

(3013512) EKG study

702

5242

1.20

4.15

6.2

2.7

—

(3009871) Measles virus Ab [Titer] in Serum

3.46

4.08

1.2

1.5

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

414

1.64

4.06

1.2

1.1

—

(3017704) Immunofixation for Urine

2.83

4.06

1.2

1.8

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

4.13

4.04

1.1

1.0

mmol/l

1.1

2.0

—

(3022145) Colonoscopy Study observation

169

1972

0.72

4.04

1.3

—

(42529406) Shigella sp [Presence] in Stool by Culture

416

1.63

3.99

1.2

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

182

2086

0.74

3.88

1.5

1.3

—

(4010399)

180

1147

1.37

3.88

1.4

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

7.67

3.86

1.3

—

(3034988) Calcium [Moles/volume] in Capillary blood

7.67

3.86

4.0

2.7

mmol/l

1.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

270

1.77

3.81

1.7

iu/l

2.4

4.7

1.78

(3002385) Erythrocyte distribution width [Ratio]

1628

14963

0.86

3.79

35.3

12.2

14.4

13.5

56.64

1578

14493

(3002179) Metamyelocytes/100 leukocytes in Blood

179

1146

1.37

3.75

4.3

3.9

0.5

0.6

0.40

246

(3016750) Collection duration of Urine

2.88

3.75

2.2

1.5

min

472.8

523.2

0.95

(3037121) Protein [Mass/volume] in Urine

464

1.58

3.74

3.4

2.9

g/l

0.4

0.2

1.31

184

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

317

1.70

3.74

1.4

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

247

1.79

3.70

1.4

1.5

—

(3044007) Cell count panel - Peritoneal fluid

3.80

3.65

2.3

1.4

—

(3014891) Appearance of Pleural fluid

6.91

3.64

2.5

1.7

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

6.91

3.64

1.0

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

2.73

3.62

1.2

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

2.73

3.62

1.2

1.5

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

456

1.56

3.57

1.5

1.4

ug/g

245.5

278.2

0.75

269

(3017181) Myelocytes/100 leukocytes in Blood

192

1254

1.34

3.56

4.3

4.0

0.8

1.0

0.37

333

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

111

2.18

3.55

1.1

1.2

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

406

2921

1.23

3.48

3.0

2.5

e6/l

1.2

1.0

0.86

248

1643

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

208

1.83

3.47

1.3

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

10.36

3.44

1.2

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

7.55

3.40

4.1

2.4

mmol/l

1.2

—

(3000012) Reticulocyte production index

2.38

3.40

2.1

1.4

—

(3016879) Cocaine [Presence] in Urine

307

1.67

3.37

3.8

2.0

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

763

5835

1.17

3.34

3.8

3.3

mmol/l

2.3

5.30

655

4929

(3025468) Yersinia sp identified in Specimen by Organism specific culture

193

1.84

3.29

1.3

1.5

—

(3021440) Promyelocytes/100 leukocytes in Blood

182

1194

1.33

3.29

4.4

4.1

0.1

0.2

0.04

302

(3011288) Drugs identified in Urine by Screen method

212

1.80

3.29

6.1

2.7

—

(3011412) CD3 cells [#/volume] in Blood

121

2.08

3.27

1.7

2.7

e9/l

1.0

1.1

0.11

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

194

1.83

3.25

1.3

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

194

1.83

3.25

1.3

1.5

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

2.49

3.23

2.3

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

116

2.09

3.22

1.1

1.3

g/l

7.4

7.2

0.06

(3024139) IgG subclass 3 [Mass/volume] in Serum

116

2.09

3.22

1.1

1.3

g/l

0.4

0.25

(3028192) IgG subclass 2 [Mass/volume] in Serum

116

2.09

3.22

1.1

1.2

g/l

2.7

3.1

0.46

(3013139) Helicobacter pylori Ag [Presence] in Stool

1112

0.68

3.20

1.2

—

(3031040) Bacteria [#/volume] in Urine by Automated count

1428

11459

1.14

3.14

5.4

3.6

e6/l

198.2

2673.4

2.01

136

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

147

1.94

3.13

3.6

4.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

2.88

3.11

1.4

2.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

197

1.80

3.11

1.4

1.5

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

5.31

3.10

1.3

1.0

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

3.60

3.10

1.5

1.2

g/l

22.0

12.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

191

1.82

3.09

1.4

1.5

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

2.27

3.08

1.7

2.5

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

309

0.42

3.06

1.1

1.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

192

1.81

3.05

1.4

1.5

—

(4062490)

120

2.02

2.97

1.1

1.2

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2021

18164

0.87

2.95

29.4

9.6

mg/l

29.1

27.3

1.65

1810

13217

(3025549) Creatine [Moles/time] in 24 hour Urine

7.40

2.95

1.5

1.7

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

228

2435

0.79

2.90

14.0

4.5

—

(3044889) 12 lead EKG panel

1533

12406

1.13

2.85

6.4

2.7

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.17

2.85

1.0

—

(3000764) Benzodiazepines [Presence] in Urine

336

1.58

2.83

4.2

1.9

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

5.49

2.83

1.9

1.7

umol/l

77.1

49.7

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

4.09

2.81

1.0

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

4.60

2.80

1.0

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

3.32

2.78

1.4

2.0

—

(3013707) Erythrocyte sedimentation rate by Westergren method

1425

13063

0.89

2.75

4.5

3.4

mm/h

17.3

10.8

31.12

1316

11696

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.06

2.72

1.0

1.1

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

486

3643

1.18

2.70

1.8

1.6

pmol/l

23573654.7

28576729.6

0.07

403

2929

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

3.89

2.69

1.0

1.1

—

(40761535) Cells panel - Urine sediment

198

1354

1.28

2.69

4.7

2.8

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

2.11

2.65

1.7

2.4

5.4

14.9

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

429

3188

1.19

2.64

3.4

3.1

mmol/l

2.5

2.4

3.57

350

2799

(3047189) Immunofixation for 24 hour Urine

2.43

2.62

1.3

2.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

183

1.75

2.60

1.3

1.4

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

2.49

2.59

5.5

1.2

ug/l

20.3

93.3

0.52

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.97

2.59

1.0

1.1

—

(3045424) Erythrocytes [Presence] in Urine

345

0.50

2.59

2.3

1.4

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

3.70

2.58

1.2

1.8

—

(3027008) Opiates [Presence] in Urine

339

1.54

2.53

4.2

1.9

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

122

1.91

2.51

2.1

1.4

u/ml

40.8

25.9

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

198

1.71

2.51

1.1

1.5

g/l

0.4

1.0

3.88

155

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

2.19

2.50

1.6

1.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1049

0.71

2.50

1.5

1.3

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

7.19

2.49

1.0

—

(3008898) HLA-B27 [Presence]

451

0.57

2.48

1.0

1.1

—

(3028300) Cannabinoids [Presence] in Urine

341

1.53

2.47

4.4

1.9

—

(3021788) Differential panel - Synovial fluid

266

1.60

2.46

1.4

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

2.05

2.46

1.9

1.2

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

5.18

2.40

1.0

u/l

15.8

7.5

—

(3007164) IgA [Mass/volume] in Serum or Plasma

356

2629

1.19

2.36

1.4

g/l

2.9

2.5

2.19

209

1432

(3025159) Blasts/100 leukocytes in Blood

165

1123

1.28

2.36

4.6

4.1

0.1

0.4

0.62

259

(3019832) Treponema pallidum Ab [Presence] in Serum

114

737

1.35

2.36

1.6

1.5

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

125

1.87

2.36

1.0

1.1

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

163

1.75

2.35

2.8

3.6

59.2

53.2

0.55

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

2.66

2.35

2.5

1.8

mmol/l

9.5

8.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

2.23

2.34

3.1

3.2

—

(3045414) Leukocytes [Presence] in Urine

786

0.68

2.33

2.8

1.7

—

(3002256) Pathology report gross observation

251

2586

0.82

2.32

1.4

1.3

—

(3008295) Osmolality of Serum or Plasma

126

1.85

2.31

1.1

1.3

mosm/kgh2o

278.8

280.4

0.12

(21494814) CD8 cells/100 lymphocytes in Specimen

2.42

2.30

1.4

2.2

—

(3042517) Benzodiazepines panel - Urine

6.16

2.29

3.8

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.88

2.25

1.5

1.2

—

(3027944) Amphetamines [Presence] in Urine

329

1.50

2.22

4.3

1.8

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.37

2.21

1.4

1.0

—

(40768793) Breast Pathology biopsy report

301

0.51

2.17

1.3

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.79

2.13

1.0

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.13

2.12

1.0

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

5.39

2.12

1.8

1.3

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

4.31

2.11

1.0

—

(1002224) Polysomnography panel

606

0.66

2.09

1.0

1.1

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

227

2329

0.83

2.03

1.2

u/ml

8.6

12.9

0.60

850

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

241

2452

0.83

1.98

1.2

iu/ml

43.3

35.6

0.31

734

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

4.79

1.96

1.4

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

1.92

1.93

1.0

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.29

1.93

1.0

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.77

1.93

1.6

1.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.20

1.90

1.3

—

(3028433) Virus identified in Specimen by Culture

2.36

1.89

1.1

—

(3006270) Folate [Moles/volume] in Blood

129

1.74

1.88

1.2

1.1

nmol/l

299.7

339.4

0.37

112

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

144

1.68

1.80

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.59

1.78

1.0

—

(21494434) Karyotype in Bone marrow

138

1.69

1.77

1.2

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.45

1.76

1.0

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.06

1.75

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

1.96

1.75

1.6

2.1

—

(3021601) Nitrite [Presence] in Urine by Test strip

886

8187

0.90

1.75

5.8

3.9

estimate

0.0

0.50

181

1427

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

211

0.49

1.73

1.4

1.5

—

(3048689) Calprotectin [Mass/mass] in Stool

168

1744

0.82

1.73

2.0

2.3

ug/g

192.7

128.7

1.01

133

1348

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

284

1.46

1.72

2.5

1.3

nmol/l

1.1

0.7

1.99

241

(3008757) Leukocyte morphology finding [Identifier] in Blood

166

1.62

1.72

2.6

3.8

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

133

1.69

1.71

1.0

1.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

1.93

1.70

1.6

2.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

1.93

1.70

1.6

2.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

1.93

1.70

1.6

2.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.88

1.66

1.6

1.5

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

621

1.30

1.63

1.2

1.3

—

(3009261) Glucose [Presence] in Urine by Test strip

900

8279

0.91

1.60

4.4

2.9

estimate

0.0

1.08

163

1385

(3043410) Blood group antigens tested for on Red Blood Cells

2.33

1.56

2.6

1.6

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

2.33

1.56

1.1

1.0

miu/ml

1831.8

1778.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

137

0.44

1.56

1.7

1.4

—

(3025577) Chromium [Mass/volume] in Blood

139

0.43

1.55

2.7

2.0

ug/l

4.6

2.0

—

122

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

516

0.70

1.53

1.6

1.8

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.32

1.49

2.4

1.3

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.43

1.47

1.8

2.3

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

242

0.57

1.46

1.3

1.4

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

2.16

1.46

1.5

1.2

—

(3044941) Cell count panel - Synovial fluid

216

1.48

1.46

1.3

—

(3011436) Histone Ab [Units/volume] in Serum

2.52

1.43

1.0

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.52

1.43

1.0

1.2

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

1.97

1.39

1.0

1.1

—

74.8

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

402

1.34

1.37

1.4

1.3

—

(3045142) Bone marrow Pathology biopsy report

177

1.51

1.36

1.4

—

(40768795) Lymph node Pathology biopsy report

181

0.52

1.35

1.2

1.3

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.59

1.33

1.0

1.3

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

1.79

1.32

1.9

2.9

34.1

33.6

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

805

6501

1.09

1.32

2.6

2.0

nmol/l

75.2

79.6

3.89

717

5612

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.82

1.31

1.1

1.0

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

309

1.37

1.30

1.1

1.2

mmol/l

4.5

3.6

3.41

288

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

117

1.62

1.30

1.6

18.5

33.4

1.60

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

1.86

1.29

1.1

1.2

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

1.95

1.27

3.3

1.9

—

(3032773) Endomysium IgG Ab [Titer] in Serum

136

0.51

1.26

1.1

—

(3035350) Ketones [Presence] in Urine by Test strip

890

8114

0.92

1.25

4.5

2.9

estimate

0.0

0.00

181

1388

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

691

6362

0.92

1.22

4.8

3.0

—

(3020393) Adenovirus Ag [Presence] in Stool

2.70

1.22

2.4

1.0

—

(40761536) Microorganisms panel - Urine sediment

185

1380

1.17

1.19

5.3

3.0

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

127

917

1.20

1.19

3.3

2.4

e6/l

0.5

0.3

0.46

122

902

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

199

1.43

1.15

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

192

1.44

1.15

2.0

2.2

u/l

30.4

3166.4

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.81

1.12

1.5

2.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.81

1.12

1.5

2.3

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.81

1.12

1.5

2.3

—

(3037556) Urate [Mass/volume] in Serum or Plasma

1.85

1.11

1.9

1.2

—

(40760892) CBC W Ordered Manual Differential panel - Blood

420

3324

1.10

1.08

5.0

4.0

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.16

1.06

1.0

1.1

—

(3048879) Bone marrow aspiration report

1.86

1.04

1.4

1.6

—

(4094501)

353

1.30

1.03

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

486

0.76

1.01

1.5

1.8

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

630

0.79

1.00

4.7

1.4

mg/l

8.0

3.6

1.22

413

(3003740) Influenza virus B Ag [Presence] in Specimen

195

0.62

1.00

1.6

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

1.66

1.00

1.1

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

1.66

1.00

1.1

1.0

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

1.73

0.99

1.4

1.1

—

(46235168) Fasting glucose [Moles/volume] in Blood

0.00

0.98

0.0

1.2

—

7.0

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.85

0.98

1.0

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

194

0.62

0.98

1.6

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

234

0.66

0.96

1.0

1.1

u/ml

0.2

2.4

—

(3014271) Vancomycin [Susceptibility]

1.61

0.95

3.6

2.6

—

(3044290) Cell count panel - Cerebral spinal fluid

275

1.32

0.94

1.0

1.3

—

(4024509)

170

0.61

0.93

1.7

1.5

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

201

0.64

0.92

1.0

1.1

u/ml

0.6

1.5

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

211

0.65

0.92

1.0

1.1

u/ml

5.1

4.2

—

100

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.73

0.92

2.4

2.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

290

0.71

0.89

1.1

2.0

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

2.07

0.89

1.0

—

(3041096) Erythrocytes [Presence] in Urine by Automated

476

4388

0.92

0.88

4.2

2.7

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

1.70

0.87

1.0

1.1

u/l

1.0

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

1.70

0.87

1.1

1.0

—

(40758292) HTLV I+II Ab panel - Serum

1.99

0.86

1.3

1.5

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

197

1.36

0.86

1.1

1.2

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.79

0.0

1.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

935

0.85

0.79

1.6

1.8

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

0.52

0.78

1.0

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

233

0.70

0.78

1.7

1.4

pmol/l

172.3

190.0

0.09

226

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

179

1.35

0.76

1.4

1.6

60.0

54.7

0.27

119

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

1.48

0.75

1.2

1.3

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

708

0.84

0.75

1.1

1.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.05

0.74

1.0

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

0.55

0.73

1.3

1.5

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

1.59

0.72

2.8

1.4

umol/l

17.6

27.6

0.76

(3006922) Hepatitis E virus Ab [Presence] in Serum

1.49

0.69

1.1

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.68

0.68

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

1.68

0.68

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.68

0.68

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.68

0.68

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

542

1.18

0.68

1.7

1.6

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.54

0.67

1.6

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

369

1.22

0.67

1.3

—

(3016018) Differential panel - Cerebral spinal fluid

139

1.37

0.66

1.0

1.3

—

(3026389) Candida sp identified in Specimen by Organism specific culture

169

1.33

0.66

1.7

1.3

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

1.47

0.66

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

1.47

0.66

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

1.47

0.66

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

254

1.26

0.64

1.4

1.3

—

(1617658) Protocol used for examination of sentinel lymph nodes

112

0.61

0.64

1.0

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

1.52

0.61

1.2

1.1

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.00

0.61

0.0

6.2

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

0.61

0.0

3.1

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.61

0.0

1.0

—

(3032057) Clostridioides difficile [Presence] in Stool

1.66

0.60

1.8

2.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

1.44

0.60

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

1.44

0.60

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

1.44

0.60

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.00

0.60

0.0

1.7

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

351

1.21

0.59

1.2

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

0.59

0.0

1.6

—

(40768797) Stomach Pathology biopsy report

277

2224

1.08

0.58

1.3

1.2

—

(3003694) ABO and Rh group [Type] in Blood

545

4914

0.95

0.56

1.4

1.3

—

(3023410) Appearance of Cerebral spinal fluid

138

0.69

0.55

1.1

1.4

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

1.51

0.55

3.7

1.7

umol/l

28.1

29.3

0.13

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

122

1.34

0.54

1.0

1.1

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

1.41

0.51

4.6

2.0

umol/l

2.1

1.8

—

(3037467) Urinalysis macro (dipstick) panel - Urine

1437

12129

1.04

0.49

5.1

3.5

—

(3000475) Leukocytes [#/volume] in Synovial fluid

367

1.18

0.49

1.5

e6/l

9565.9

9877.0

0.04

257

(4146454)

171

1.26

0.48

2.6

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

1.36

0.47

9.9

12.3

nmol/l

969.0

778.5

0.71

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

230

0.79

0.47

2.2

1.9

mg/l

24.0

28.0

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1409

12379

0.96

0.46

4.4

3.3

pmol/l

15.1

14.7

5.05

1285

10809

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

1.37

0.46

1.1

1.3

mmol/l

9.3

10.9

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.44

0.46

1.4

2.9

—

(3015183) Erythrocyte sedimentation rate

0.61

0.46

1.4

1.1

—

(4035726)

210

1689

1.08

0.46

1.6

1.3

—

(3005322) IgE [Units/volume] in Serum or Plasma

103

802

1.11

0.45

1.4

1.3

u/ml

342.3

347.0

0.01

736

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

415

0.85

0.44

1.3

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

359

0.84

0.44

1.4

2.0

—

(36660697) Celiac disease serology panel - Serum

118

1111

0.91

0.43

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

1.37

0.42

1.5

1.4

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.00

0.41

0.0

1.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.38

0.41

1.1

1.3

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

0.41

0.0

2.8

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.41

0.0

1.5

—

1.3

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.49

0.40

1.2

1.1

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

1.32

0.40

1.4

g/l

0.7

0.9

1.54

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

223

1.20

0.40

1.7

1.6

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

0.00

0.40

0.0

1.7

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

0.00

0.40

0.0

2.3

—

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

0.00

0.40

0.0

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.68

0.40

1.1

1.6

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

474

1.13

0.39

1.1

1.2

u/ml

0.2

0.4

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

264

1.18

0.38

1.1

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

1.39

0.38

1.0

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

217

1.19

0.37

1.0

1.1

iu/ml

1.2

141.4

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.29

0.37

1.1

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

832

0.91

0.37

1.4

1.7

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

0.63

0.36

1.0

1.1

—

7.9

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

414

1.13

0.34

1.5

iu/ml

0.4

6.0

0.68

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

180

1.20

0.33

1.2

mmol/l

8.0

7.6

0.21

124

(3014051) Protein [Presence] in Urine by Test strip

357

0.87

0.33

3.3

2.0

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

446

3711

1.04

0.33

4.1

3.0

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

342

3067

0.96

0.33

1.2

u/ml

1.1

2.0

1.68

724

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

1.29

0.32

1.2

2.8

ug/l

1.6

1.2

—

(44806420)

1.37

0.31

1.6

2.4

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

631

1.09

0.31

2.0

3.7

u/ml

2849.3

586.2

0.41

544

(3020491) Glucose [Moles/volume] in Blood

113

0.76

0.30

1.6

2.0

mmol/l

9.1

6.5

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

1.32

0.30

1.1

1.2

u/l

251.5

1238.0

1.07

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

398

0.89

0.29

2.1

3.5

u/ml

104.5

438.5

1.20

369

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

334

0.88

0.29

1.1

1.2

—

44.6

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

1.26

0.28

1.9

1.4

u/ml

3.7

2.6

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

378

0.89

0.27

3.2

2.6

mg/l

34.0

28.3

0.40

210

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1.26

0.27

1.3

1.2

—

(4027681)

1.31

0.26

1.1

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

1.26

0.25

1.6

1.4

—

(3019225) pH of Specimen

227

2038

0.96

0.25

5.8

3.0

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.19

0.25

1.3

1.2

—

(3000494) Fungus identified in Specimen by Culture

241

1996

1.04

0.24

1.8

1.4

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.35

0.23

1.2

—

(4015189)

1.27

0.22

3.8

2.7

—

(3024316) Viscosity of Plasma

0.00

0.21

0.0

2.2

—

1.8

—

(3001729) Color of Synovial fluid

0.00

0.21

0.0

1.7

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.00

0.21

0.0

2.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

0.21

0.0

1.1

—

(3004959) Base excess in Arterial cord blood by calculation

0.00

0.21

0.0

1.0

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3006598) pH of Arterial cord blood

0.00

0.21

0.0

1.0

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.00

0.21

0.0

1.5

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

103

838

1.06

0.21

1.2

iu/ml

98.6

138.6

0.84

310

(3029396) Erythrocyte agglutination [Presence] in Blood

0.00

0.21

0.0

3.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.16

0.21

2.0

1.5

ug/l

12.9

9.2

—

(3049717) Cytology report of Urine Cyto stain

103

839

1.06

0.21

2.7

3.0

—

(4281824)

125

0.83

0.20

1.5

1.1

—

(42870560) Thyrotropin [Units/volume] in Cord blood

0.00

0.20

0.0

1.0

—

15.4

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

1.23

0.20

1.3

1.2

g/l

0.3

—

(3025130) Human papilloma virus identified in Specimen

109

1.19

0.20

1.9

1.7

—

(4133840)

1.20

0.20

1.7

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

1.22

0.20

1.4

—

1.4

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

102

1.18

0.18

1.4

2.5

e6/l

910.0

539.7

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

1.20

0.18

1.0

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

183

1633

0.96

0.17

1.6

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1282

10939

1.02

0.17

4.2

2.7

u/l

83.3

47.1

13.99

1175

9873

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

131

0.85

0.16

1.0

1.2

—

100.8

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

1.13

0.16

6.2

7.9

—

(40768443) Skin Pathology biopsy report

823

0.95

0.16

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

184

0.89

0.15

1.2

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

318

0.92

0.15

1.1

1.2

u/ml

5.0

4.8

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

1.18

0.14

1.1

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

379

1.07

0.14

1.3

1.6

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

113

1.14

0.14

1.0

1.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

171

1.11

0.13

1.0

1.1

u/ml

1.5

2.8

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

296

1.08

0.13

1.2

1.4

e6/l

73.0

1108.9

1.37

230

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

296

1.08

0.13

1.1

1.3

e6/l

6.3

20.0

0.51

220

(3023511) Choriogonadotropin [Units/volume] in Urine

0.83

0.13

1.3

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

128

0.87

0.13

1.5

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

483

1.05

0.12

3.8

3.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

148

1.11

0.11

1.3

—

(4034850)

544

1.05

0.11

19.7

6.6

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

117

0.88

0.10

2.6

1.8

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

1.10

0.10

1.6

1.1

74.8

49.4

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

100

1.12

0.09

2.3

1.4

—

65.0

—

(40765096) Chromosome analysis panel by Banding

1.04

0.08

1.1

—

(44813793)

1.11

0.07

1.2

1.1

—

(3029937) Albumin [Presence] in Urine by Test strip

512

4451

0.99

0.07

4.9

3.2

estimate

0.0

0.99

156

1372

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

114

0.91

0.07

1.7

1.5

—

(3024263) Appearance of Synovial fluid

0.84

0.06

1.1

1.7

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

237

0.94

0.06

1.3

1.2

—

(3017732) Neutrophils [#/volume] in Blood

137

1203

0.98

0.06

3.0

2.9

e9/l

4.3

3.9

0.70

106

877

(3019150) Specific gravity of Urine by Refractometry

412

3582

0.99

0.06

4.8

3.2

kg/l

1.0

0.94

527

(3022621) pH of Urine by Test strip

126

1102

0.98

0.04

2.9

2.6

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

320

0.97

0.03

1.2

1.3

iu/l

30.0

28.9

0.08

267

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

182

1.04

0.02

1.6

1.7

—

2129.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

229

1985

0.99

0.02

3.0

4.5

ug/l

3.9

19.9

2.98

196

1654

(3000330) Specific gravity of Urine by Test strip

860

0.99

0.01

4.0

2.8

—

(40768441) Liver Pathology biopsy report

1.06

0.01

1.3

1.2

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

277

1.00

0.00

1.1

1.2

—

29.3

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

106

914

1.00

0.00

2.4

—

(3035320) C reactive protein [Mass/volume] in Body fluid

111

1.01

0.00

2.1

2.0

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

0.98

0.00

1.0

1.2

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

125

1.03

0.00

1.1

1.3

—

59.6

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

139

0.99

0.00

2.9

1.7

u/field

1.1

2.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

167

0.98

0.00

1.1

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.0

1.2

—

8.7

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.2

—

1.7

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.0

1.2

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.0

1.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.6

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.0

5.3

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.00

0.0

1.1

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

0.0

1.0

—

(4211845)

0.91

0.00

2.5

3.7

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

1.8

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

0.0

1.0

—

(3006462) Nitrate [Presence] in Urine

0.94

0.00

2.5

3.8

—

Mortality – FinRegistry

↥

Association

Association between endpoint I9_CARDARR and mortality.

Females

Parameter	HR [95% CI]	p-value
I9_CARDARR	3.397 [2.88, 4.0]	< 0.001
Birth year	0.991 [0.98, 1.0]	0.045

During the follow-up period (1.1.1998 — 31.12.2019), 1471 out of 3106 females with I9_CARDARR died.

Males

Parameter	HR [95% CI]	p-value
I9_CARDARR	3.423 [2.99, 3.92]	< 0.001
Birth year	0.989 [0.98, 1.0]	0.014

During the follow-up period (1.1.1998 — 31.12.2019), 3038 out of 6961 males with I9_CARDARR died.

Mortality risk

Mortality risk for people of age

years, who have I9_CARDARR.

N-year risk	Females	Males
1	0.272%	0.581%
5	1.763%	3.492%
10	4.451%	9.208%
15	8.304%	17.494%
20	13.989%	28.944%

Relationships between endpoints

↥

Index endpoint: I9_CARDARR – Cardiac arrest

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Cardiac arrest

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints